Mahsa Jalili

Dr. Mahsa Jalili


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MJMahsa Jalili
Mahsa Jalili
KSKourosh Sayehmiri
Kourosh Sayehmiri
NANastaran Ansari
Nastaran Ansari
BPBehzad Pourhossein
Behzad Pourhossein
MFMaryam Fazeli
Maryam Fazeli
FJFarid Azizi Jalilian
Farid Azizi Jalilian
There is a lot of evidence to suggest that patients infected with the COVID-19 and influenza viruses are at risk of atherosclerosis. Additionally, there are heterogeneous studies on the risk of arthrosclerosis in patients infected with the influenza and COVID-19 viruses. We conducted a case–control and cross-sectional study and examined the association between the risk of atherosclerosis, and influenza virus (IV-A and IV-B) and COVID-19 infections in this study. We searched for keywords such as influenza virus, COVID-19 and atherosclerosis in English and Persian in well-known databases such as PubMed, SID, Magiran and Google Scholar. In this study, we analyzed the information using a meta-analysis, the random effect model, the I2 index and STAT (version 11.2). The results from the analysis of ten studies on influenza virus and nine studies on COVID-19 reviewed individually (totaling 6428 samples for influenza virus infections and 10,785 samples for COVID-19 infections) demonstrated a risk of arthrosclerosis in patients with influenza and COVID-19 infections, with an OR (odds ratio) = 0.45 ((95% CI): 0.25 to 0.64) and an OR (odds ratio) = 1.04 ((95% CI): 0.82 to 1.26), respectively. The present study provides new insights into the risk of atherosclerosis in patients infected with the COVID-19 and influenza viruses. Therefore, it seems necessary to consider different strategies for managing and eradicating viral infections among individuals.

1 December 2021
Verified
Open access
PDF file
MJMahsa Jalili
Mahsa Jalili
SSSomayeh Sharifi
Somayeh Sharifi
KAKhadijeh Abdal
Khadijeh Abdal
FDFahimeh Daneshyar
Fahimeh Daneshyar
Despite major advances in oral health in the past decades, tooth decay is one of the most common preventable diseases in the worldwide. Nowadays, Streptococcus mutans is discussed as one of the most important challenges in tooth decay. Also, medicinal herbs can be considered as an effective weapon against infectious diseases. The purpose of the current study was to investigate the biofilm formation in S. mutans clinical isolates and to evaluate the anti-biofilm properties of Crocus sativus against S. mutans clinical isolates. In this study, thirty dental plaque samples were collected. Then, identification of samples was performed by standard methods. Biofilm formation was evaluated on S. mutans clinical isolates. C. sativus alcoholic extract was applied as an anti-biofilm formation in this isolates. Our results demonstrated that a significant number of S. mutans samples were identified as biofilm producers. Then, C. sativus in 60 mg/ml, 30 mg/ml and 8 mg/ml were able to eradicated strong, moderate and week biofilm formation in thisisolates, respectively. In addition, more extensive studies and in vivo research are needed to confirm the results of this study.